Skip to main content

TC Group, LLC's Form 4 filing

Jasper Therapeutics, Inc. (JSPR) · filed Jan 31, 2023

Accession no.
0000899243-23-003059
Filed
Jan 31, 2023, 5:24 PM ET
Trade date
Jan 27, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $4.70M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
TC Group, LLCCIK 000093379010% Owner
Carlyle Investment Management LLCCIK 000135412010% Owner
Abingworth LLPCIK 000139714410% Owner
Carlyle Group Inc.CIK 000152716610% Owner
Carlyle Holdings I GP Inc.CIK 000154862610% Owner
Carlyle Holdings I GP Sub L.L.C.CIK 000154862710% Owner
Carlyle Holdings I L.P.CIK 000154862810% Owner
CG Subsidiary Holdings L.L.C.CIK 000179057710% Owner
Carlyle Genesis UK LLCCIK 000194186010% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 27, 2023Voting Common StockPPurchaseAcquired+3,133,333$1.50+$4,699,999.58,761,891Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)